The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.

US regulators approved Moderna Inc.’s COVID-19 vaccine for children, but for a narrower group than before, continuing Robert ...

SILVER SPRING, MD — The FDA gives full approval for Moderna’s COVID-19 vaccine in children aged 6 months through 11 years who ...

The Food and Drug Administration (FDA) granted full approval on Thursday to Moderna’s COVID-19 vaccine for children, making it the first COVID shot for kids aged 6 months to 11 years old that is ...

Dame Jacinda Ardern says she will provide evidence to assist the Royal Commission of Inquiry into the Covid-19 response. This week there was speculation about whether the former prime minister, who is ...

Pfizer's COVID vaccine (Comirnaty) is fully approved for patients ages 12 and up, and authorized for kids ages 6 months ...

Three deaths reported nationally as Ohio's outbreak ends with 35 cases, while Texas accounts for 753 infections in the ...

Vaccine maker Moderna announced today that the US Food and Drug Administration (FDA) has granted full approval of its ...

House Oversight Committee Democrats are demanding a briefing with staff from the Centers for Disease Control and Prevention about Health Secretary Robert F. Kennedy Jr.’s newly remade ...

The full approval of Spikevax covers children aged six months through 11 years who are at increased risk for severe COVID-19, transitioning the vaccine from emergency use to full licensure.

The US FDA has granted full approval to Moderna’s COVID-19 vaccine Spikevax for use in children aged six months to 11 years ...

Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 3.8% in the morning session after the U.S. Food and Drug ...